Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. We show 10 historical shares outstanding datapoints in our coverage of EVGN's shares outstanding history.
Understanding the changing numbers of EVGN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like EVGN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching EVGN by allowing them to research EVGN shares outstanding history
as well as any other stock in our coverage universe. |
Free EVGN Email Alerts:
Video: Shares Outstanding Importance
